Arcellx Competitors and Similar CompaniesClear all
Arcellx's competitors and similar companies include Ayala Pharmaceuticals, IO Biotech, Cullgen and AgomAb Therapeutics.
 Ayala Pharmaceuticals Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined. |  IO Biotech IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies. |  Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders. |  AgomAb Therapeutics AgomAb Therapeutics is a biotherapeutics company developing molecular therapies for the regeneration of damaged tissues. | ||
Founding Date | Founding Date 2015 | Founding Date 2017 | Founding Date 2014 | Founding Date 2018 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Gaithersburg, US HQ | Locations Wilmington, US HQ Rehovot, IL Wilmington, US | Locations New York, US HQ København, DK Usk, GB Rockville, US | Locations San Diego, US HQ Shanghai, CN Tokyo, JP | Locations Antwerpen, BE HQ Gent, BE |
Employees | Employees 78 | Employees 29 | Employees 19 | Employees 4 | Employees 62 |
Valuation ($) | Valuation ($) 4.7 b | Valuation ($) 7.4 m | Valuation ($) 85.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $22.3m (FY, 2025) | Revenue (est.) $692k (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($228.9m) (FY, 2025) | Net income ($38m) (FY, 2022) | Net income ($95.5m) (FY, 2024) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 200m | Total funding raised $ 47m | Total funding raised $ 165.9m | Total funding raised $ 31m | Total funding raised $ 97.6m |
For sources of this data, please see the company profile
View Company Profiles
Ayala Pharmaceuticals
HQ
Wilmington, US
Employees
29
Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined.
View companyIO Biotech
HQ
New York, US
Employees
19
IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies.
View companyCullgen
HQ
San Diego, US
Employees
4
Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.
View companyAgomAb Therapeutics
HQ
Antwerpen, BE
Employees
62
AgomAb Therapeutics is a biotherapeutics company developing molecular therapies for the regeneration of damaged tissues.
View company